{"schema_version":"1","generated_at":"2026-11-08T02:05:40.119Z","data_as_of":null,"url":"https://www.findmykol.com/kol/lohith-gowda","json_url":"https://www.findmykol.com/kol/lohith-gowda/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"lohith-gowda","name":"Lohith Gowda","credential":"MD","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"institution":"Yale Cancer Center","institution_url":"https://www.findmykol.com/institution/yale-school-of-medicine","city":"New Haven","state":"CT","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1669610168","orcid":"0009-0001-1726-9749","openalex":"A5090669888"},"summary":"Lohith Gowda is a Hematology physician affiliated with Yale Cancer Center. OpenAlex indexes 111 publications with 1,133 citations (h-index 20); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"works_count":111,"cited_by_count":1133,"h_index":20,"latest_activity_year":2025,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT06180863","title":"Oral Azacitidine (CC-486) Epigenetic Priming and Maintenance for Adult Acute Myeloid Leukemia (AML) Patients","phase":"PHASE2","status":"WITHDRAWN","role":"Overall official","sponsor":"Yale University","source_url":"https://clinicaltrials.gov/study/NCT06180863","trial_url":"https://www.findmykol.com/trial/NCT06180863"}],"source":"trials"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":3,"shown":3,"withheld":0,"rows":[{"payer":"Incyte","program_year":2025,"amount_usd":75401.4,"payment_count":41,"source_url":"https://openpaymentsdata.cms.gov/search?query=1669610168"},{"payer":"Bristol Myers Squibb","program_year":2024,"amount_usd":51510.41,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1669610168"},{"payer":"Celgene Corporation","program_year":2021,"amount_usd":3460,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1669610168"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1669610168","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Standard-of-care idecabtagene vicleucel for relapsed/refractory multiple myeloma","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood.2024026216","status":"verified"},{"title":"Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR","year":2025,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2025016141","status":"verified"},{"title":"Teduglutide for treatment-refractory severe intestinal acute graft-versus-host disease - a multicenter survey","year":2025,"journal":"Bone Marrow Transplantation","source_url":"https://doi.org/10.1038/s41409-025-02586-2","status":"verified"},{"title":"Safety and Efficacy of Ciltacabtagene Autoleucel for Relapsed/Refractory Multiple Myeloma: A CIBMTR Study","year":2025,"journal":"Clinical Lymphoma Myeloma & Leukemia","source_url":"https://doi.org/10.1016/s2152-2650(25)03469-x","status":"verified"},{"title":"Efficacy and safety of frail adults treated with ciltacabtagene autoleucel in the real-world: A CIBMTR analysis","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-133","status":"verified"}],"source":"works"},"contact":{"address_1":"SMILOW CANCER CENTER, 35 PARK STREET","city":"New Haven","state":"CT","zip":"06510","phone":"203-688-4242","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1669610168","source":"identity"},"similar":[{"name":"Ian Krop","slug":"ian-krop","institution":"Yale Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/ian-krop","json_url":"https://www.findmykol.com/kol/ian-krop/profile.json"},{"name":"Harriet Kluger","slug":"harriet-kluger","institution":"Yale Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/harriet-kluger","json_url":"https://www.findmykol.com/kol/harriet-kluger/profile.json"},{"name":"Stephanie Halene","slug":"stephanie-halene","institution":"Yale Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/stephanie-halene","json_url":"https://www.findmykol.com/kol/stephanie-halene/profile.json"},{"name":"John Kunstman","slug":"john-kunstman","institution":"Yale Cancer Center","specialty":"Surgical Oncology","url":"https://www.findmykol.com/kol/john-kunstman","json_url":"https://www.findmykol.com/kol/john-kunstman/profile.json"},{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"},{"name":"Jaroslaw Maciejewski","slug":"jaroslaw-maciejewski","institution":"Cleveland Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/jaroslaw-maciejewski","json_url":"https://www.findmykol.com/kol/jaroslaw-maciejewski/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2017-09-28","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}